Cantin M, Garcia R, Thibault G, Kuchel O, Gutkowska J, Larochelle P, Hamet P, Schiffrin E L, Genest J
Multidisciplinary Research Group on Hypertension, Clinical Research Institute of Montreal, Quebec, Canada.
Clin Invest Med. 1987 Nov;10(6):561-7.
The plasma levels of immunoreactive (IR)-ANF have been evaluated by radioimmunoassay in several models of experimental hypertension and in human hypertension. In all models of experimental hypertension so far studied, the plasma levels of IR-ANF are consistently increased. This is accompanied by a decrease, at certain time intervals, of the IR-ANF levels in the left atrium. In human essential hypertension, the plasma levels of IR-ANF are not increased except in the severe form (diastolic blood pressure above 110 mmHg). In renovascular hypertension, the peripheral levels of IR-ANF are not different from the normal levels but are increased above normal in aortic blood.
通过放射免疫测定法已对几种实验性高血压模型和人类高血压患者的免疫反应性(IR)-心钠素血浆水平进行了评估。在迄今为止所研究的所有实验性高血压模型中,IR-心钠素的血浆水平持续升高。这伴随着在某些时间间隔左心房中IR-心钠素水平的降低。在人类原发性高血压中,IR-心钠素的血浆水平除非在严重形式(舒张压高于110 mmHg)下否则不会升高。在肾血管性高血压中,外周血IR-心钠素水平与正常水平无差异,但主动脉血中的水平高于正常。